BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
COLM
Columbia Sportswear Company
COLM has the edge over BABA overall, supported by stronger fundamentals and stronger valuation.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
COLM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
COLM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
COLM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $69.30 | -3.3% |
| Current | 16x | $71.64 | — |
| Forward | 17x | $71.64 | — |
| Fair | 18x | $83.30 | +16% |
| Expensive | 26x | $117 | +63% |
Historical ranges are pointers, not guarantees.
COLM has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
COLM Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for COLM, with profitability improving.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over COLM on earnings, with more consistent year-over-year improvement.
COLM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.34 | -4.8% |
| Q3 2026 | $4.56 | +40% |
| Q2 2026 | $3.85 | -0.5% |
| Q1 2026 | $3.14 | -19% |
| Q4 2025 | $3.24 | -15% |
| Q3 2025 | $3.26 | -8.9% |
| Q2 2025 | $3.87 | +4% |
| Q1 2025 | $3.86 | -4.9% |
| Q4 2024 | $3.82 | -6.6% |
COLM earned $4.56 per share over the past year, up 40% from the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over COLM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
COLM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $962.6M | +2% |
| Q2 2026 | $614.4M | +1.5% |
| Q1 2026 | $779M | +0.1% |
| Q4 2025 | $1.1B | -2.4% |
| Q3 2025 | $943.4M | +1.3% |
| Q2 2025 | $605.2M | +6.1% |
| Q1 2025 | $778.5M | +1.1% |
| Q4 2024 | $1.1B | +3.5% |
COLM's revenue fell from its 2022 peak and has held roughly level since: $963M last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +4.3 points |
| Q2 2026 | 5% | +8.9 points |
| Q1 2026 | 5.4% | -0.6 points |
| Q4 2025 | 11% | -1.6 points |
| Q3 2025 | 7.1% | -4.9 points |
| Q2 2025 | -3.9% | +0.3 points |
| Q1 2025 | 6% | +0.2 points |
| Q4 2024 | 13% | +1.8 points |
COLM has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
COLM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$333M | -$45.8M |
| Q2 2026 | $101.6M | +$147M |
| Q1 2026 | -$90M | -$42.4M |
| Q4 2025 | $596.8M | +8.6% |
| Q3 2025 | -$287.2M | -$87.7M |
| Q2 2025 | -$45.3M | -$34.4M |
| Q1 2025 | -$47.6M | -152% |
| Q4 2024 | $549.6M | -8.5% |
COLM has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
COLM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -318K shares |
| 1 year | -6.6% | -3.6M shares |
| 3 years | -16% | -10M shares |
| 5 years | -23% | -15.3M shares |
| Available history | -26% | -17.5M shares |
COLM has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50M |
| Q2 2026 | — |
| Q1 2026 | $150M |
| Q4 2025 | $29.4M |
| Q3 2025 | $40M |
| Q2 2025 | $30.3M |
| Q1 2025 | $101.4M |
| Q4 2024 | $86.9M |
COLM spent $229M buying back its own shares over the past year, down 11% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
COLM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -1.7x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
COLM has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
COLM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 92.5 | Overbought |
COLM's weekly RSI is 71 (overbought) and its Stochastic is 93 (overbought).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
COLM PE vs Consumer Cyclical Sector
| Metric | COLM | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 13% below |
| PE % | 21 | 47 | 26 pts below |
COLM has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
COLM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.9 | 14% above |
| 20 week MA | $61.0 | 18% above |
| 50 week MA | $60.0 | 19% above |
| 100 week MA | $62.8 | 14% above |
| 200 week MA | $71.6 | 0.1% above |
COLM has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
COLM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $99.7 | $90.2 | -9.5% |
| 2021 | $90.2 | $93.8 | +4% |
| 2022 | $93.8 | $85.9 | -8.4% |
| 2023 | $85.9 | $79.5 | -7.4% |
| 2024 | $79.5 | $85.8 | +7.8% |
| 2025 | $85.8 | $55.6 | -35% |
| 2026 YTD | $55.6 | $71.6 | +29% |
COLM has the edge over BABA on returns for 2026, with the stronger performance.